We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$718M
AUM Growth
+$77.8M
Cap. Flow
+$50.4M
Cap. Flow %
7.02%
Top 10 Hldgs %
87.06%
Holding
84
New
10
Increased
11
Reduced
19
Closed
32

Top Buys

Rank Stock Value
1
GRPN icon
Groupon
GRPN
+$47.8M
2
SHEL icon
Shell
SHEL
+$20.7M
3
TDOC icon
Teladoc Health
TDOC
+$6.37M
4
CGAU
Centerra Gold
CGAU
+$6.31M
5
BABA icon
Alibaba
BABA
+$5.86M

Top Sells

Rank Stock Value
1
BP icon
BP
BP
+$12.6M
2
NOMD icon
Nomad Foods
NOMD
+$4.38M
3
PPLI
People Inc
PPLI
+$4.24M
4
NE icon
Noble Corp
NE
+$3.81M
5
TRIP icon
TripAdvisor
TRIP
+$3.44M

Sector Composition

Rank Sector Weight
1 Energy 46.93%
2 Communication Services 23.62%
3 Consumer Staples 14.75%
4 Consumer Discretionary 4.54%
5 Industrials 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOMO
26
Hello Group
MOMO
$885M
$675K 0.09%
+108,772
New +$690K
FSM icon
27
Fortuna Silver Mines
FSM
$2.55B
$522K 0.07%
140,000
– –
RNW icon
28
ReNew
RNW
$2.27B
$423K 0.06%
70,451
-9,749
-12% -$64.2K
MLYS icon
29
Mineralys Therapeutics
MLYS
$2.25B
$373K 0.05%
28,915
-5,828
-17% -$72K
QURE icon
30
uniQure
QURE
$3.03B
$341K 0.05%
65,600
– –
CMPX icon
31
Compass Therapeutics
CMPX
$344M
$249K 0.03%
125,968
-55,087
-30% -$95.2K
ERAS icon
32
Erasca
ERAS
$6.3B
$231K 0.03%
111,906
-74,195
-40% -$148K
CELC icon
33
Celcuity
CELC
$4.21B
$222K 0.03%
10,269
-4,140
-29% -$66.1K
PASG icon
34
Passage Bio
PASG
$14.4M
$191K 0.03%
7,072
-21,991
-76% -$529K
ATYR
35
aTyr Pharma
ATYR
$47.6M
$178K 0.02%
91,232
-202,474
-69% -$353K
TCRX icon
36
TScan Therapeutics
TCRX
$48.6M
$171K 0.02%
21,573
– –
BDTX icon
37
Black Diamond Therapeutics
BDTX
$96.8M
$171K 0.02%
33,697
-17,403
-34% -$70.2K
MNKD icon
38
CALL
MannKind Corp
MNKD
$1.21B
$168K 0.02%
37,100
+12,100
+48% +$47.5K
IOVA icon
39
Iovance Biotherapeutics
IOVA
$1.82B
$163K 0.02%
11,000
-6,024
-35% -$70.1K
PRLD icon
40
Prelude Therapeutics
PRLD
$366M
$149K 0.02%
31,481
-32,100
-50% -$125K
AVXL icon
41
CALL
Anavex Life Sciences
AVXL
$255M
$117K 0.02%
+23,000
New +$129K
IGMS
42
DELISTED
IGM Biosciences
IGMS
$112K 0.02%
11,601
– –
CRBU icon
43
Caribou Biosciences
CRBU
$145M
$112K 0.02%
21,700
-6,500
-23% -$40.1K
CMRX
44
DELISTED
Chimerix, Inc.
CMRX
$111K 0.02%
104,796
-106,418
-50% -$111K
RVNC
45
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
$98.4K 0.01%
+20,000
New +$118K
RVPH
46
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$94.5K 0.01%
+1,250
New +$99.1K
HUMA icon
47
CALL
Humacyte
HUMA
$176M
$69K 0.01%
22,200
-9,900
-31% -$33.3K
CDTX
48
DELISTED
Cidara Therapeutics
CDTX
$61.2K 0.01%
3,327
– –
PBYI icon
49
CALL
Puma Biotechnology
PBYI
$404M
$53K 0.01%
+10,000
New +$53.9K
XFOR icon
50
X4 Pharmaceuticals
XFOR
$375M
$52.9K 0.01%
+1,269
New +$35.3K
1
2
3 4

Similar funds

WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return

Pale Fire Capital SE's Q1 2024 Portfolio in Review

As of Q1 2024, Pale Fire Capital SE held 84 positions worth $718M, up 12% from $640M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Pale Fire Capital SE deployed $50.4M of net new capital in Q1 2024, opening 10 new positions and adding to 11 existing holdings. Its largest new stake was Kinross Gold: 700,000 shares worth $4.29M.

By sector, the portfolio is most concentrated in Energy at 47% of assets, down from 48% a quarter earlier, followed by Communication Services and Consumer Staples.

On the sell side, the largest reduction was Nomad Foods, an estimated $4.38M trimmed.

  • Pale Fire Capital SE's largest Q1 2024 buy was Kinross Gold: 700,000 shares worth $4.29M.
  • Pale Fire Capital SE added most to Groupon in Q1 2024, an estimated $47.8M increase.
  • Pale Fire Capital SE's biggest Q1 2024 reduction was Nomad Foods, cutting an estimated $4.38M.
  • Pale Fire Capital SE fully exited BP in Q1 2024, selling an estimated $12.6M.
  • Pale Fire Capital SE's ten largest holdings make up 87% of its $718M portfolio in Q1 2024.
  • Pale Fire Capital SE opened 10 new positions and closed 32 in Q1 2024.
  • Pale Fire Capital SE's portfolio value rose 12% quarter-over-quarter to $718M.

Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.